Lack of Detection of the Analgesic Properties of PF‐05089771, a Selective Nav1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects
Sodium channel blockers are used for the treatment of pain, but this is limited by the lack of selectivity for different sodium channel subtypes, which can result in central nervous system and cardiovascular side effects. As such, there is special interest in the Nav1.7 subtype, which is expressed p...
Main Authors: | Pieter Siebenga, Guido vanAmerongen, Justin L. Hay, Aoibhinn McDonnell, Donal Gorman, Richard Butt, Geert Jan Groeneveld |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.12712 |
Similar Items
-
Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain
by: Jennifer R. Deuis, et al.
Published: (2016-03-01) -
Molecular delineation of cyathostome species
by: McDonnell, Aoibhinn
Published: (1999) -
Oral administration of PF-01247324, a subtype-selective Nav1.8 blocker, reverses cerebellar deficits in a mouse model of multiple sclerosis.
by: Shannon D Shields, et al.
Published: (2015-01-01) -
Discovery of a Novel Nav1.7 Inhibitor From Cyriopagopus albostriatus Venom With Potent Analgesic Efficacy
by: Yunxiao Zhang, et al.
Published: (2018-10-01) -
Selective Closed-State Nav1.7 Blocker JZTX-34 Exhibits Analgesic Effects against Pain
by: Xiongzhi Zeng, et al.
Published: (2018-02-01)